DE eng

Search in the Catalogues and Directories

Hits 1 – 12 of 12

1
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.
In: Alzheimer's & dementia (Amsterdam, Netherlands), vol 13, iss 1 (2021)
BASE
Show details
2
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.
In: Alzheimer's & dementia (Amsterdam, Netherlands), vol 13, iss 1 (2021)
BASE
Show details
3
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring
In: Alzheimers Dement (Amst) (2021)
BASE
Show details
4
Longitudinal structural and metabolic changes in frontotemporal dementia
In: Neurology (2020)
BASE
Show details
5
Differential cognitive substrates of verbal episodic memory performance in semantic variant primary progressive aphasia and Alzheimer’s disease
In: J Neuropsychol (2020)
BASE
Show details
6
Data from: Longitudinal structural and metabolic changes in frontotemporal dementia ...
BASE
Show details
7
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
In: Annals of clinical and translational neurology, vol 5, iss 10 (2018)
BASE
Show details
8
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
In: Annals of clinical and translational neurology, vol 5, iss 10 (2018)
BASE
Show details
9
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.
Abstract: BackgroundDegradation of white matter microstructure has been demonstrated in frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD). In preparation for clinical trials, ongoing studies are investigating the utility of longitudinal brain imaging for quantification of disease progression. To date only one study has examined sample size calculations based on longitudinal changes in white matter integrity in FTLD.ObjectiveTo quantify longitudinal changes in white matter microstructural integrity in the three canonical subtypes of frontotemporal dementia (FTD) and AD using diffusion tensor imaging (DTI).Methods60 patients with clinical diagnoses of FTD, including 27 with behavioral variant frontotemporal dementia (bvFTD), 14 with non-fluent variant primary progressive aphasia (nfvPPA), and 19 with semantic variant PPA (svPPA), as well as 19 patients with AD and 69 healthy controls were studied. We used a voxel-wise approach to calculate annual rate of change in fractional anisotropy (FA) and mean diffusivity (MD) in each group using two time points approximately one year apart. Mean rates of change in FA and MD in 48 atlas-based regions-of-interest, as well as global measures of cognitive function were used to calculate sample sizes for clinical trials (80% power, alpha of 5%).ResultsAll FTD groups showed statistically significant baseline and longitudinal white matter degeneration, with predominant involvement of frontal tracts in the bvFTD group, frontal and temporal tracts in the PPA groups and posterior tracts in the AD group. Longitudinal change in MD yielded a larger number of regions with sample sizes below 100 participants per therapeutic arm in comparison with FA. SvPPA had the smallest sample size based on change in MD in the fornix (n=41 participants per study arm to detect a 40% effect of drug), and nfvPPA and AD had their smallest sample sizes based on rate of change in MD within the left superior longitudinal fasciculus (n=49 for nfvPPA, and n=23 for AD). BvFTD generally showed the largest sample size estimates (minimum n=140 based on MD in the corpus callosum). The corpus callosum appeared to be the best region for a potential study that would include all FTD subtypes. Change in global measure of functional status (CDR box score) yielded the smallest sample size for bvFTD (n=71), but clinical measures were inferior to white matter change for the other groups.ConclusionsAll three of the canonical subtypes of FTD are associated with significant change in white matter integrity over one year. These changes are consistent enough that drug effects in future clinical trials could be detected with relatively small numbers of participants. While there are some differences in regions of change across groups, the genu of the corpus callosum is a region that could be used to track progression in studies that include all subtypes.
Keyword: 2.1 Biological and endogenous factors; Acquired Cognitive Impairment; AD; Aged; Aging; Alzheimer Disease; Alzheimer's Disease; Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD); Alzheimer's Disease Related Dementias (ADRD); Behavioral and Social Science; Behavioral variant FTD; Biomedical Imaging; Brain; Brain Disorders; Clinical Research; Clinical trial; Clinical Trials and Supportive Activities; Cross-Sectional Studies; Dementia; Diffusion Tensor Imaging; DTI; Female; Frontotemporal Dementia; Frontotemporal Dementia (FTD); FTD; Humans; Longitudinal; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative; Neurological; Neurosciences; Primary progressive aphasia; Rare Diseases; Retrospective Studies; Sample Size; White Matter; White matter integrity
URL: https://escholarship.org/uc/item/36t974qr
BASE
Hide details
10
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.
Elahi, Fanny M; Marx, Gabe; Cobigo, Yann. - : eScholarship, University of California, 2017
BASE
Show details
11
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.
In: Brain and behavior, vol 7, iss 4 (2017)
BASE
Show details
12
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.
In: Brain and behavior, vol 7, iss 4 (2017)
BASE
Show details

Catalogues
0
0
0
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
12
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern